Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Chemotherapy-Induced Nausea and Vomiting (CINV) Global Market Report 2024

Chemotherapy-Induced Nausea and Vomiting (CINV) Global Market Report 2024 – By Form (Injectables, Oral, Transdermal Patches), By Drug Class (5-HT3 Receptor Antagonists, Neurokinin-1 Receptor Antagonists, Corticosteroids, Cannabinoids, Other Drug Class), By Emetogenic Risk (Highly Emetogenic Chemotherapy (HEC), Moderately Emetogenic Chemotherapy (MEC), Low Emetogenic Chemotherapy (LEC)), By Distribution Channel (CINV Hospitals, Cancer Research Institute, Retail Pharmacies, Online Pharmacies, Drug Stores), By Application (Gynecology, Urology, Gastrointestinal Surgery, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

Chemotherapy-Induced Nausea and Vomiting (CINV) Global Market Report 2024

Starting Price : $5000.00 | Pages : 175 | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
Customise Your Report
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Chemotherapy Induced Nausea and Vomiting CINV Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Chemotherapy-Induced Nausea And Vomiting (CINV) Market Definition And Segments

Chemotherapy-induced nausea and vomiting (CINV) is a condition that causes nausea and vomiting sensation, which can develop due to chemotherapy treatment. It is a prevalent side-effect affecting many cancer patients, affecting their quality of life and treatment results. CINV can be managed and treated through medications and lifestyle changes.

The main types of forms of chemotherapy-induced nausea and vomiting (CINV) are injectables, oral and transdermal patches. Injectables are chemicals that are injected into the body to have various effects. The various drug classes are 5-HT3 receptor antagonists, neurokinin-1 receptor antagonists, corticosteroids, cannabinoids and others and various emetogenic risks are highly emetogenic chemotherapy (HEC), moderately emetogenic chemotherapy (MEC) and low emetogenic chemotherapy (LEC). The various distribution channels are CINV hospitals, cancer research institutes, retail pharmacies, online pharmacies and drug stores applied in gynecology, urology, gastrointestinal surgery and others.

The chemotherapy-induced nausea and vomiting (cinv) market covered in this report is segmented –

1) By Form: Injectables, Oral, Transdermal Patches

2) By Drug Class: 5-HT3 Receptor Antagonists, Neurokinin-1 Receptor Antagonists, Corticosteroids, Cannabinoids, Other Drug Class

3) By Emetogenic Risk: Highly Emetogenic Chemotherapy (HEC), Moderately Emetogenic Chemotherapy (MEC), Low Emetogenic Chemotherapy (LEC)

4) By Distribution Channel: CINV Hospitals, Cancer Research Institute, Retail Pharmacies, Online Pharmacies, Drug Stores

5) By Application: Gynecology, Urology, Gastrointestinal Surgery, Other Applications

The chemotherapy-induced nausea and vomiting (cinv) market size has grown strongly in recent years. It will grow from $2.69 billion in 2023 to $2.92 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to growth in chemotherapy use, improved antiemetic agents, clinical guidelines, patient advocacy.

The chemotherapy-induced nausea and vomiting (cinv) market size is expected to see strong growth in the next few years. It will grow to $3.88 billion in 2028 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to personalized medicine, advances in antiemetic agents, telehealth and remote monitoring, health equity initiatives. Major trends in the forecast period include combination antiemetic therapies, supportive care services, digital health tools, survivorship care.

Rising Cancer Prevalence Spurs Growth In The Chemotherapy-Induced Nausea And Vomiting (CINV) Market

The increasing prevalence of cancer is expected to propel the growth of chemotherapy-induced nausea and vomiting (CINV) market going forward. Cancer is when some cells in the body develop uncontrolled and spread to other body regions. As cancer cases continue to grow, there is a greater incentive to develop more effective and targeted anti-emetic treatments to alleviate CINV, a distressing side effect of chemotherapy. This heightened focus on CINV management has led to advancements in understanding its underlying mechanisms and developing novel therapies. For instance, in January 2023, according to the American Cancer Society (ACS), a US-based volunteer health organization committed to cancer eradication, in the United States, it is anticipated to be 1.9 million new cancer cases (approximately 5,370 cases per day) and 609,820 cancer deaths (about 1,670 deaths per day) in 2023. Therefore, the increasing prevalence of cancer will drive the chemotherapy-induced nausea and vomiting (CINV) market.

Impact Of Favorable Regulatory Initiatives On The Chemotherapy-Induced Nausea And Vomiting (CINV) Market

The increasing favorable regulatory initiatives are expected to propel the growth of the chemotherapy-induced nausea and vomiting (CINV) market going forward. Regulatory initiatives are actions taken by regulatory bodies to develop, implement, or enforce regulations. Regulatory initiatives can be used to improve the prevention and management of chemotherapy-induced nausea and vomiting (CINV) to develop and implement guidelines for the prevention and management of CINV. For instance, in May 2021, according to the Food and Drug Administration, a US-based federal agency protecting public health, the FDA released a draft guidance for businesses to aid with the clinical development of medications for the treatment of CINV in adults. Therefore, the increasing favorable regulatory initiatives are driving the growth of the chemotherapy-induced nausea and vomiting (CINV) market.

Major players in the chemotherapy-induced nausea and vomiting (cinv) market are Pfizer Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Novartis AG, AstraZeneca PLC, GlaxoSmithKline PLC, Baxter International Inc., Teva Pharmaceuticals Industries Ltd., Bausch Health Companies Inc., Eisai Co. Ltd., Jazz Pharmaceuticals PLC, Ono Pharmaceutical Co. Ltd., Dr. Reddy’s Laboratories Ltd., Kyowa Kirin Inc., Amneal Pharmaceuticals Inc., Mundipharma International Limited, Insys Therapeutics Inc., Lupin Limited, Helsinn Holding S.A., Heron Therapeutics Inc., Camurus AB, Cadila Pharmaceuticals Limited, Acacia Pharma Ltd., Soligenix Inc.

High Cost Of Cinv Drugs Is Impacting The Market Growth

The high cost of chemotherapy-induced nausea and vomiting (CINV), which can limit access to treatment and impact market growth. The high cost of CINV drugs refers to the increased prices of drugs used to prevent or treat chemotherapy-induced nausea and vomiting (CINV). The high cost of CINV drugs can significantly impede the growth of the chemotherapy-induced nausea and vomiting (CINV) market by limiting patient access to therapies and reducing overall market demand. For instance, in September 2022, as per the study published in the National Center for Biotechnology Information (NCBI), a US-based medical library, the cost of CINV episode management by cycle of chemotherapy was estimated at €31.51 per patient. The study also reported that the mean cost per patient per severe CINV episode resulted in approximately €389 in Italy, €750 in France, and €1017 in Germany, which indicates the high cost of drugs and overall treatment. Therefore, the high cost of CINV drugs is impacting the growth of the chemotherapy-induced nausea and vomiting (CINV) market.

Leading Companies In The Cinv Market Pioneering Transdermal Delivery System (TDS) Innovations

Major companies operating in the chemotherapy-induced nausea and vomiting (CINV) market are working on new product innovations, such as transdermal delivery systems (TDS), to meet the customer requirements in the market. A transdermal delivery system (TDS) is a drug delivery system that allows the controlled release of a medication through the skin for systemic absorption. For instance, in April 2021, Starton Therapeutics Inc., a US-based biotechnology company, announced the FDA approval for STAR-OLZ transdermal delivery system (TDS) to treat chemotherapy-induced nausea and vomiting (CINV). STAR-OLZ is a multi-day olanzapine transdermal delivery system (TDS) covering the duration of the five-day CINV therapy. Independent double-blind trials have revealed that olanzapine is a potent antiemetic, outperforming other standard-of-care therapies, including NK1 receptor antagonists, regarding nausea management. STAR-OLZ previously completed Phase 1 in-human bioavailability (BA) trials, demonstrating that the transdermal patch has acceptable local tolerability during a 5-day dosing interval and provides roughly 60% less medication than the oral version.

Cumberland Pharmaceuticals Expands Cinv Portfolio With Acquisition Of Sancuso From Kyowa Kirin Inc

In January 2022, Cumberland Pharmaceuticals Inc., a US-based specialty pharmaceutical company, acquired SANCUSO (granisetron transdermal patch) from Kyowa Kirin Inc. for $13.5 million. With this acquisition, Cumberland will obtain the U.S. rights to SANCUSO (chemotherapy-induced nausea and vomiting (CINV) drug and will take full commercial responsibility for the product, including its marketing, promotion, distribution, manufacturing and medical support operations. Kyowa Kirin Inc. is a US-based subsidiary of Kyowa Kirin Co. Ltd. (Japan), a specialty pharmaceutical that develops innovative medicines used to prevent CINV.

North America was the largest region in the chemotherapy-induced nausea and vomiting (CINV) market in 2023. The regions covered in chemotherapy-induced nausea and vomiting (CINV) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the chemotherapy-induced nausea and vomiting (CINV) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The chemotherapy-induced nausea and vomiting (CINV) market consists of revenues earned by entities by providing services such as pharmacologic therapy and nonpharmacologic therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The chemotherapy-induced nausea and vomiting (CINV) market also includes the sales of such as olanzapine, dexamethasone, cannabinoids, metoclopramide, promethazine and prochlorperazine. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The chemotherapy-induced nausea and vomiting (CINV) market research report is one of a series of new reports from The Business Research Company that provides chemotherapy-induced nausea and vomiting (CINV) market statistics, including chemotherapy-induced nausea and vomiting (CINV) industry global market size, regional shares, competitors with a chemotherapy-induced nausea and vomiting (CINV) market share, detailed chemotherapy-induced nausea and vomiting (CINV) market segments, market trends and opportunities and any further data you may need to thrive in the chemotherapy-induced nausea and vomiting (CINV) industry. This chemotherapy-induced nausea and vomiting (CINV) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Chemotherapy-Induced Nausea and Vomiting (CINV) Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $2.92 billion
Revenue Forecast In 2033 $3.88 billion
Growth Rate CAGR of 7.4% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Form: Injectables, Oral, Transdermal Patches
2) By Drug Class: 5-HT3 Receptor Antagonists, Neurokinin-1 Receptor Antagonists, Corticosteroids, Cannabinoids, Other Drug Class
3) By Emetogenic Risk: Highly Emetogenic Chemotherapy (HEC), Moderately Emetogenic Chemotherapy (MEC), Low Emetogenic Chemotherapy (LEC)
4) By Distribution Channel: CINV Hospitals, Cancer Research Institute, Retail Pharmacies, Online Pharmacies, Drug Stores
5) By Application: Gynecology, Urology, Gastrointestinal Surgery, Other Applications
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Pfizer Inc.; Roche Holding AG; Merck & Co. Inc.; AbbVie Inc.; Novartis AG; AstraZeneca plc; GlaxoSmithKline plc; Baxter International Inc.; Teva Pharmaceuticals Industries Ltd.; Bausch Health Companies Inc.; Eisai Co. Ltd.; Jazz Pharmaceuticals plc; Ono Pharmaceutical Co. Ltd.; Dr. Reddy’s Laboratories Ltd.; Kyowa Kirin Inc.; Amneal Pharmaceuticals Inc.; Mundipharma International Limited; Insys Therapeutics Inc.; Lupin Limited; Helsinn Holding S.A.; Heron Therapeutics Inc.; Camurus AB; Cadila Pharmaceuticals Limited; Acacia Pharma Ltd.; Soligenix Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Characteristics

    3. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Trends And Strategies

    4. Chemotherapy-Induced Nausea and Vomiting (CINV) Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size and Growth

    5.1. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Segmentation

    6.1. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Injectables

    Oral

    Transdermal Patches

    6.2. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    5-HT3 Receptor Antagonists

    Neurokinin-1 Receptor Antagonists

    Corticosteroids

    Cannabinoids

    Other Drug Class

    6.3. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Emetogenic Risk, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Highly Emetogenic Chemotherapy (HEC)

    Moderately Emetogenic Chemotherapy (MEC)

    Low Emetogenic Chemotherapy (LEC)

    6.4. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    CINV Hospitals

    Cancer Research Institute

    Retail Pharmacies

    Online Pharmacies

    Drug Stores

    6.5. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Gynecology

    Urology

    Gastrointestinal Surgery

    Other Applications

    7. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Regional And Country Analysis

    7.1. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market  

    8.1. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Overview  

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Chemotherapy-Induced Nausea and Vomiting (CINV) Market  

    9.1. China Chemotherapy-Induced Nausea and Vomiting (CINV) Market Overview  

    9.2. China Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Chemotherapy-Induced Nausea and Vomiting (CINV) Market  

    10.1. India Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Chemotherapy-Induced Nausea and Vomiting (CINV) Market  

    11.1. Japan Chemotherapy-Induced Nausea and Vomiting (CINV) Market Overview  

    11.2. Japan Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Chemotherapy-Induced Nausea and Vomiting (CINV) Market  

    12.1. Australia Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Chemotherapy-Induced Nausea and Vomiting (CINV) Market  

    13.1. Indonesia Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Chemotherapy-Induced Nausea and Vomiting (CINV) Market  

    14.1. South Korea Chemotherapy-Induced Nausea and Vomiting (CINV) Market Overview  

    14.2. South Korea Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market  

    15.1. Western Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Overview

    15.2. Western Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Chemotherapy-Induced Nausea and Vomiting (CINV) Market  

    16.1. UK Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Chemotherapy-Induced Nausea and Vomiting (CINV) Market  

    17.1. Germany Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Chemotherapy-Induced Nausea and Vomiting (CINV) Market  

    18.5. France Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Chemotherapy-Induced Nausea and Vomiting (CINV) Market  

    19.9. Italy Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Chemotherapy-Induced Nausea and Vomiting (CINV) Market  

    20.13. Spain Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market  

    21.1. Eastern Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Overview

    21.2. Eastern Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Chemotherapy-Induced Nausea and Vomiting (CINV) Market  

    22.1. Russia Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market  

    23.1. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Overview

    23.2. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Chemotherapy-Induced Nausea and Vomiting (CINV) Market  

    24.1. USA Chemotherapy-Induced Nausea and Vomiting (CINV) Market Overview

    24.2. USA Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Chemotherapy-Induced Nausea and Vomiting (CINV) Market  

    25.1. Canada Chemotherapy-Induced Nausea and Vomiting (CINV) Market Overview

    25.2. Canada Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Chemotherapy-Induced Nausea and Vomiting (CINV) Market  

    26.1. South America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Overview

    26.2. South America Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Chemotherapy-Induced Nausea and Vomiting (CINV) Market  

    27.1. Brazil Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Chemotherapy-Induced Nausea and Vomiting (CINV) Market  

    28.1. Middle East Chemotherapy-Induced Nausea and Vomiting (CINV) Market Overview

    28.2. Middle East Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market  

    29.1. Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Overview

    29.2. Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Competitive Landscape And Company Profiles

    30.1. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Competitive Landscape

    30.2. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Company Profiles

    30.2.1. Pfizer Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Roche Holding AG

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Merck & Co. Inc.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. AbbVie Inc.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Novartis AG

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Other Major And Innovative Companies

    31.1. AstraZeneca plc

    31.2. GlaxoSmithKline plc

    31.3. Baxter International Inc.

    31.4. Teva Pharmaceuticals Industries Ltd.

    31.5. Bausch Health Companies Inc.

    31.6. Eisai Co. Ltd.

    31.7. Jazz Pharmaceuticals plc

    31.8. Ono Pharmaceutical Co. Ltd.

    31.9. Dr. Reddy’s Laboratories Ltd.

    31.10. Kyowa Kirin Inc.

    31.11. Amneal Pharmaceuticals Inc.

    31.12. Mundipharma International Limited

    31.13. Insys Therapeutics Inc.

    31.14. Lupin Limited

    31.15. Helsinn Holding S.A.

    32. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Competitive Benchmarking

    33. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Chemotherapy-Induced Nausea and Vomiting (CINV) Market

    35. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Future Outlook and Potential Analysis

    35.1 Chemotherapy-Induced Nausea and Vomiting (CINV) Market In 2028 - Countries Offering Most New Opportunities

    35.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Market In 2028 - Segments Offering Most New Opportunities

    35.3 Chemotherapy-Induced Nausea and Vomiting (CINV) Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Emetogenic Risk, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: Asia-Pacific, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: China, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: India, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Japan, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Australia, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: Indonesia, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: South Korea, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: Western Europe, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: UK, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: Germany, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: France, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Italy, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Spain, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Eastern Europe, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: Russia, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: North America, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: USA, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: Canada, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: South America, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Brazil, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Middle East, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: Africa, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 76: Pfizer Inc. Financial Performance
  • Table 77: Roche Holding AG Financial Performance
  • Table 78: Merck & Co. Inc. Financial Performance
  • Table 79: AbbVie Inc. Financial Performance
  • Table 80: Novartis AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Emetogenic Risk, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: Asia-Pacific, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: China, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: India, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Japan, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Australia, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: Indonesia, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: South Korea, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: Western Europe, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: UK, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: Germany, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: France, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Italy, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Spain, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Eastern Europe, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: Russia, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: North America, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: USA, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: Canada, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: South America, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Brazil, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Middle East, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: Africa, Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 76: Pfizer Inc. Financial Performance
  • Figure 77: Roche Holding AG Financial Performance
  • Figure 78: Merck & Co. Inc. Financial Performance
  • Figure 79: AbbVie Inc. Financial Performance
  • Figure 80: Novartis AG Financial Performance
Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis
Read More
How Will The Nuclear Medicine Market Grow In 2022?
Read More
What Is The Pediatric Imaging Market Overview In 2022?
Read More
Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth
Read More
Viral Vectors And Plasmid DNA Global Market Report 2024 – By Product (Plasmid DNA, Viral Vectors), By Disease (Infectious Diseases, Genetic Disorders, Cancer, Other Diseases), By Application (Gene And Cancer Therapies, Viral Infections, Immunotherapy, Formulation Development, Other Applications), By End User (Research Institutes, Biopharmaceutical And Pharmaceutical Companies) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Report 2024 – By Drug Class (Nerve Protective Therapy, Anti-Inflammatory Therapy, Neurotransmitter Based Therapy, Antioxidant, Other Drug Classes), By Treatment (Medication, Therapy, Other Treatments), By Drug Type (Branded, Generic), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacies, Other Distribution Channels), By End-User (Hospitals, Research Institutes, Specialty Clinics) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Chemotherapy-Induced Anemia Global Market Report 2024 – By Anemia (Mild Anemia, Moderate Anemia, Severe Anemia, Life-Threatening Anemia), By Treatment Type (RBC (Red Blood Cells) Transfusion, Erythropoiesis-Stimulating Agents (ESAs), Iron Supplementation), By End-User (Hospitals, Ambulatory Surgical Centers, Multispecialty Clinics, Cancer Research Centers, Cancer Rehabilitation Centers) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cancer biologics Global Market Report 2024 – By Type (Monoclonal Antibodies, Vaccines, Cell And Gene Therapy, Other Types), By Application (Non-small Cell Lung Cancer, Prostate Cancer, Breast Cancer, Acute Myeloid Leukemia, Lymphoma, Multiple Myeloma, Ovarian Cancer, Colorectal Cancer, Gastric Cancers, Other Applications), By Distribution Channel (Hospitals, Clinics, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cancer Clinical Decision Tools Global Market Report 2024 – By Type (Risk Assessment Tool (RAT), Qcancer), By End-User (Hospital, Clinics) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cancer Diagnostics Global Market Report 2024 – By Products (Companion Diagnostics, Molecular Diagnostics), By Method (Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging), By Application (Cervical Cancer, Breast Cancer, Liver Cancer, Blood Cancer, Kidney Cancer, Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Melanoma, Other Applications), By End-User (Cancer Research Institutes, Diagnostic Laboratories, Hospitals, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cancer Monoclonal Antibodies Global Market Report 2024 – By Monoclonal Antibody Therapies (Avastin, Herceptin, Keytruda, Opdivo, Darzalex, Perjeta, Others), By Application (Breast Cancer, Blood Cancer, Lung Cancer, Brain Tumor, Colorectal Cancer, Cervical Cancer, Gastric Cancer, Others), By End-User (Hospitals, Research Laboratories, Others) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cancer Vaccines Global Market Report 2024 – By Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines), By Technology (Dendritic Cells (DC) Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines, Whole Cell Cancer Vaccines, Viral Vector & DNA Cancer Vaccines), By Cancer Type (Prostate, Cervical, Colorectal, Throat, Other Cancer Types), By End-User (Cancer Treatment Centers, Research Institutes) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the chemotherapy-induced nausea and vomiting (CINV) market?

Chemotherapy-induced nausea and vomiting (CINV) is a condition that causes nausea and vomiting sensation, which can develop due to chemotherapy treatment. It is a prevalent side-effect affecting many cancer patients, affecting their quality of life and treatment results. CINV can be managed and treated through medications and lifestyle changes. request a sample here

How will the chemotherapy-induced nausea and vomiting (CINV) market drivers and restraints affect the chemotherapy-induced nausea and vomiting (CINV) market dynamics? What forces will shape the chemotherapy-induced nausea and vomiting (CINV) industry going forward?

The chemotherapy-induced nausea and vomiting (CINV) market major growth driver - Rising Cancer Prevalence Spurs Growth In The Chemotherapy-Induced Nausea And Vomiting (CINV) Market. request a sample here

What is the forecast market size or the forecast market value of the chemotherapy-induced nausea and vomiting (CINV) market?

The chemotherapy-induced nausea and vomiting (CINV) market size has grown strongly in recent years. It will grow from $2.69 billion in 2023 to $2.92 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to growth in chemotherapy use, improved antiemetic agents, clinical guidelines, patient advocacy. The chemotherapy-induced nausea and vomiting (CINV) market size is expected to see strong growth in the next few years. It will grow to $3.88 billion in 2028 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to personalized medicine, advances in antiemetic agents, telehealth and remote monitoring, health equity initiatives. Major trends in the forecast period include combination antiemetic therapies, supportive care services, digital health tools, survivorship care. request a sample here

How is the chemotherapy-induced nausea and vomiting (CINV) market segmented?

The chemotherapy-induced nausea and vomiting (CINV) market is segmented
1) By Form: Injectables, Oral, Transdermal Patches
2) By Drug Class: 5-HT3 Receptor Antagonists, Neurokinin-1 Receptor Antagonists, Corticosteroids, Cannabinoids, Other Drug Class
3) By Emetogenic Risk: Highly Emetogenic Chemotherapy (HEC), Moderately Emetogenic Chemotherapy (MEC), Low Emetogenic Chemotherapy (LEC)
4) By Distribution Channel: CINV Hospitals, Cancer Research Institute, Retail Pharmacies, Online Pharmacies, Drug Stores
5) By Application: Gynecology, Urology, Gastrointestinal Surgery, Other ApplicationsFor further insights on the chemotherapy-induced nausea and vomiting (CINV) market request a sample here

Which region has the largest share of the chemotherapy-induced nausea and vomiting (CINV) market? What are the other regions covered in the report?

North America was the largest region in the chemotherapy-induced nausea and vomiting (CINV) market in 2023. The regions covered in chemotherapy-induced nausea and vomiting (CINV) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. request a sample here.

Who are the major players in the chemotherapy-induced nausea and vomiting (CINV) market?

Major players in the chemotherapy-induced nausea and vomiting (CINV) market are Pfizer Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Novartis AG, AstraZeneca PLC, GlaxoSmithKline PLC, Baxter International Inc., Teva Pharmaceuticals Industries Ltd., Bausch Health Companies Inc., Eisai Co. Ltd., Jazz Pharmaceuticals PLC, Ono Pharmaceutical Co. Ltd., Dr. Reddy’s Laboratories Ltd., Kyowa Kirin Inc., Amneal Pharmaceuticals Inc., Mundipharma International Limited, Insys Therapeutics Inc., Lupin Limited, Helsinn Holding S.A., Heron Therapeutics Inc., Camurus AB, Cadila Pharmaceuticals Limited, Acacia Pharma Ltd., Soligenix Inc. request a sample here.

What are the key trends in the chemotherapy-induced nausea and vomiting (CINV) market?

Major trend in the chemotherapy-induced nausea and vomiting (CINV) market - Leading Companies In The Cinv Market Pioneering Transdermal Delivery System (TDS) Innovations. request a sample here.

What are the major opportunities in the chemotherapy-induced nausea and vomiting (CINV) market? What are the strategies for the chemotherapy-induced nausea and vomiting (CINV) market?

For detailed insights on the major opportunities and strategies in the chemotherapy-induced nausea and vomiting (CINV) market, request a sample here.

How does the chemotherapy-induced nausea and vomiting (CINV) market relate to the overall economy and other similar markets?

For detailed insights on chemotherapy-induced nausea and vomiting (CINV) market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the chemotherapy-induced nausea and vomiting (CINV) industry?

For detailed insights on the mergers and acquisitions in the chemotherapy-induced nausea and vomiting (CINV) industry, request a sample here.

What are the key dynamics influencing the chemotherapy-induced nausea and vomiting (CINV) market growth? SWOT analysis of the chemotherapy-induced nausea and vomiting (CINV) market.

For detailed insights on the key dynamics influencing the chemotherapy-induced nausea and vomiting (CINV) market growth and SWOT analysis of the chemotherapy-induced nausea and vomiting (CINV) industry, request a sample here.